17 – 23 March 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Stem cell study for people with highly active relapsing MS shows promising results
Preliminary data from an international stem cell study for people with highly active relapsing multiple sclerosis has reported that those having stem cell treatment had fewer relapses and improved disability levels.
Siponimod secondary progressive MS results published in Lancet
Results from a large clinical trial of siponimod for secondary progressive MS (SPMS) have been published in the Lancet. Those taking siponimod had a 21% reduced risk of progression.
MS Trust link: Siponimod trial results